InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Van Nostrand Robert l, Director. Insider active across 4 companies, notably Intra-Cellular Therapies, Inc.. In total, 32 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €13k. History available since 30 June 2021. The latest transaction was disclosed on 7 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Van Nostrand Robert l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
50,000 shares0Common StockSEC:0001104659-26-002511:0
10,000 shares@ US$1.48100.0% of flowCommon StockSEC:0001104659-25-059166:0
Canonical exit: 10 Sept 2025 (T+90)
11,340 shares@ US$132.0055.3% of flowCommon StockSEC:0000950170-25-049636:0
12,500 shares0Common StockSEC:0001104659-25-003497:0
83 shares@ US$68.490.2% of flowCommon StockSEC:0000950170-24-080987:0
1,567 sharesCommon StockSEC:0000950170-24-077472:0
20,000 shares@ US$16.8612.6% of flowCommon StockSEC:0000950170-24-076380:0
79 shares@ US$69.200.2% of flowCommon StockSEC:0000950170-24-040166:0
11,924 shares0Common StockSEC:0001628280-24-013923:0
20,000 shares@ US$18.5613.8% of flowCommon StockSEC:0000950170-24-022485:0
6,000 shares0Common StockSEC:0001104659-24-006381:0
18,879 shares0Common StockSEC:0001628280-24-000210:0
76 shares@ US$71.620.2% of flowCommon StockSEC:0000950170-24-001303:0
105 shares@ US$52.090.2% of flowCommon StockSEC:0001209191-23-051143:0
13,868 shares0Common StockSEC:0001121702-23-000056:0
85 shares@ US$63.320.2% of flowCommon StockSEC:0001209191-23-041084:0
2,040 shares0Common StockSEC:0001628280-23-024201:0
10,000 shares@ US$13.054.8% of flowCommon StockSEC:0001209191-23-024899:0
95 shares@ US$54.150.2% of flowCommon StockSEC:0001209191-23-022799:0
1,642 shares0Common StockSEC:0001628280-23-010704:0
2,500 shares0Common StockSEC:0001104659-23-010623:0
97 shares@ US$52.920.2% of flowCommon StockSEC:0001209191-23-000197:0
110 shares@ US$46.530.2% of flowCommon StockSEC:0001209191-22-052716:0
20,000 shares@ US$12.459.7% of flowCommon StockSEC:0001209191-22-045685:0
108 shares@ US$57.080.2% of flowCommon StockSEC:0001209191-22-040571:0
25 of 32 declarations
About Van Nostrand Robert l
VAN NOSTRAND ROBERT L is a Director and has 32 filings in total. In the 32 recent filings we hold, the reported amounts are EUR 12,758 for buys and EUR 1,372,190 for sells, with a date range from 2016-01-05 to 2026-01-09. The companies mentioned are Intra-Cellular Therapies, Inc., SELLAS Life Sciences Group, Inc., YIELD10 BIOSCIENCE, INC. and Enumeral Biomedical Holdings, Inc., and the most common transaction nature is Attribution.
